Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

BioLife Solutions Inc

BLFS ✓ COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Medical Equipment, Supplies & Distribution ·

USA Small Cap Analyst: HOLD

Last Close

$35.07

▼ -0.45%

Market Cap $1.72B · Vol 191.06K

Key Metrics

P/E Ratio

34.21

FWD: 85.10

Market Cap

$1.72B

Small Cap

Div Yield

N/A

EPS Growth

+632.00%

YoY

RSI (14)

86.07

Momentum

Beta

1.91

vs Market

52W High

$35.34

0.76% below

52W Low

$17.86

96.36% above

Volume

191.06K

Avg 340.36K

P/B

3.13

Price-to-book

ROE

-1.27%

Return on equity

Free Float

97.50%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, BioLife Solutions Inc (BLFS) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does BLFS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+1.18%

+22.41%

+66.52%

+57.76%

YTD

+45.04%

+38.51%

+185.82%

-22.62%

Financials & Valuation

TTM · Annual

Total Revenue	$96.21M
Net Income	$-12,130,000.00
Revenue Growth (YoY)	+21.45%
Gross Margin	64.29%
Operating Margin	-1.12%
Net Profit Margin	-12.61%
ROE	-1.27%
ROA · ROIC	-3.00% · N/A

P/E Ratio	34.21
Forward P/E (FY1)	85.10
PEG Ratio	N/A
P/S	12.00
P/B	3.13
P/FCF	N/A
EPS Growth	+632.00%
Outstanding Shares	48.91M

Technical Indicators

50-Day SMA	$29.38
200-Day SMA	$24.70
RSI (14)	86.07
Beta	1.91
52-Week High	$35.34
52-Week Low	$17.86

Volume Today	191.06K
Avg Daily Volume (30D)	340.36K
Relative Volume	0.56x
Volatility (10D)	20.34
Volatility (30D)	38.31
Free Float	97.50%

Analyst Consensus

HOLD

Current Price $35.07

Mean Target $31.29

52W Low$17.86 52W High$35.34

Current

Target

$17.86 $35.34

Current Analyst target

-10.79% downside risk · 9 analysts

Identifiers

ExchangeNasdaq

FIGIBBG001SFGWZ7

ISINUS09062W2044

CountryUnited States of America

Sub-IndustryMedical Equipment, Supplies & Distribution (NEC)

Earnings DateNov 9, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

ABT Abbott Laboratories -0.02% MDT Medtronic PLC +0.76% COR Cencora Inc +1.23% 7741.T Hoya Corp +0.32% BDX Becton Dickinson and Co +0.79%

Company Profile

BioLife Solutions, Inc. is a developer and supplier of cell processing tools and services for the cell and gene therapy (CGT) market. The Company facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during the collection, development, manufacturing and distribution. Its CryoStor freeze media and HypoThermosol hypothermic storage media are optimized to preserve cells in the cell and gene therapy market. Its Sexton cell processing product line includes human platelet lysates (hPL) for cell expansion. Its CellSeal closed systems are purpose-built rigid containers used in cell and gene therapy (CGT). Its CryoCase cryo-compatible transparent rigid containers are designed for closed-system fill and retrieval, and automated cell processing machines. The Company's ThawSTAR product line comprises a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags.